Comparison

CID5721353 European Partner

Item no. TMO-T3940-200mg
Manufacturer TargetMol
CASRN 301356-95-6
Amount 200 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 1 mg 200 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Formula C15H9BrN2O6S2
Smiles OC(=O)CC(N1C(=S)S\C(C1=O)=C1\C(=O)Nc2ccc(Br)cc12)C(O)=O
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias BCL6 inhibitor
Shipping Condition Cool pack
Available
Manufacturer - Targets
Apoptosis|||Bcl-2 Family
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
457.28
Description
CID5721353 (BCL6 inhibitor) is a B-Cell Lymphoma 6 Inhibitor (BCL6 inhibitor) that disrupts BCL6/corepressor complexes in vitro and in vivo, and was shown to bind the critical site within the BTB groove.
Pathways
Apoptosis
Bioactivity
CID5721353 is a B-Cell Lymphoma 6 Inhibitor (BCL6 inhibitor) that disrupts BCL6/corepressor complexes in vitro and in vivo, and was shown to bind the critical site within the BTB groove.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close